P. Martin Petkovich,Joel Z. Melnick,Jay A. White,Samir P. Tabash,Charles W. Bishop,Susan Peers,Stepehn A. Strugnell
申请号：
US16700329
公开号：
US20200101089A1
申请日:
2019.12.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D are disclosed. The 25-hydroxyvitamin D may be administered with an agent that increases the risk of hypocalcemia, such as cinacalcet or a salt thereof, and/or an anticancer agent. The adjunctive therapy is effective to treat and prevent iatrogenic hypocalcemia and/or secondary hyperparathyroidism, as well as delay cancer progression and the time to a post-treatment skeletal related event.
